Driving in the melanoma landscape.

Abstract excerpt

The melanoma landscape is rapidly evolving. The melanoma oncologists have now the first successful targets for therapy that have a genetic base--albeit in rare forms of the malignancy. Once melanoma becomes part of the Cancer Genome Atlas consortium, a comprehensive map of genetic changes will be established to point the field to true drivers of the disease that will become new targets for therapy. The same...

Topics

Join the communities discussing this publication.

• Drug Delivery Systems
• Drug Design
• Extracellular Matrix Proteins
• Forecasting
• Intercellular Signaling Peptides and Proteins